Capricorn Fund Managers Ltd Has $14.77 Million Holdings in Phibro Animal Health Corporation $PAHC

Key Points

• Capricorn Fund Managers increased its stake in Phibro Animal Health by 45.1% in the first quarter, ending with 267,045 shares valued at about $14.77 million. The holding makes PAHC its 13th largest position and represents 2.3% of its portfolio.
• Institutional ownership remains very high, with 99.34% of Phibro Animal Health shares held by institutions and hedge funds. Several major firms, including Vanguard, State Street, and Millennium Management, also reported sizable positions.
• Analysts have turned more cautious on PAHC, with recent downgrades leaving the stock at an overall Hold consensus and a target price of $42.50. Shares were trading around $31.40, while the company recently beat quarterly EPS and revenue estimates and continued paying a quarterly dividend.

Capricorn Fund Managers Ltd increased its position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 45.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 267,045 shares of the company's stock after purchasing an additional 82,944 shares during the quarter. Phibro Animal Health accounts for approximately 2.3% of Capricorn Fund Managers Ltd's investment portfolio, making the stock its 13th largest position. Capricorn Fund Managers Ltd owned 0.66% of Phibro Animal Health worth $14,770,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of Phibro Animal Health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 1,539,593 shares of the company's stock worth $57,519,000 after acquiring an additional 13,884 shares during the period. State Street Corp raised its position in Phibro Animal Health by 5.4% during the fourth quarter. State Street Corp now owns 942,279 shares of the company's stock valued at $35,204,000 after purchasing an additional 48,243 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Phibro Animal Health by 4,227.1% in the 4th quarter. Millennium Management LLC now owns 641,313 shares of the company's stock valued at $23,959,000 after purchasing an additional 626,492 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Phibro Animal Health by 4.0% in the 4th quarter. Geode Capital Management LLC now owns 569,111 shares of the company's stock valued at $21,265,000 after purchasing an additional 21,951 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Phibro Animal Health by 1.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 492,335 shares of the company's stock worth $18,394,000 after buying an additional 6,826 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on PAHC shares. Zacks Research downgraded Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research report on Thursday, May 21st. Citigroup lowered their target price on Phibro Animal Health from $62.00 to $44.00 and set a "neutral" rating for the company in a research note on Thursday, May 14th. Wall Street Zen cut shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 9th. Finally, Weiss Ratings downgraded shares of Phibro Animal Health from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Monday, June 15th. One equities research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, Phibro Animal Health presently has an average rating of "Hold" and a consensus target price of $42.50.

Phibro Animal Health Trading Down 1.3%

Shares of PAHC stock opened at $31.40 on Wednesday. Phibro Animal Health Corporation has a twelve month low of $25.34 and a twelve month high of $60.08. The stock's fifty day simple moving average is $37.81 and its 200 day simple moving average is $43.97. The company has a quick ratio of 1.26, a current ratio of 3.17 and a debt-to-equity ratio of 1.97. The firm has a market capitalization of $1.27 billion, a P/E ratio of 13.48, a P/E/G ratio of 0.48 and a beta of 0.46.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.72 by $0.04. The firm had revenue of $383.54 million during the quarter, compared to the consensus estimate of $367.02 million. Phibro Animal Health had a return on equity of 37.14% and a net margin of 6.35%.Phibro Animal Health has set its FY 2026 guidance at 2.980-3.100 EPS. As a group, sell-side analysts predict that Phibro Animal Health Corporation will post 3.08 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 24th. Investors of record on Wednesday, June 3rd were given a dividend of $0.12 per share. The ex-dividend date was Wednesday, June 3rd. This represents a $0.48 annualized dividend and a yield of 1.5%. Phibro Animal Health's dividend payout ratio (DPR) is currently 20.60%.

Insiders Place Their Bets

In other news, CEO Jack Bendheim sold 4,528 shares of Phibro Animal Health stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $48.49, for a total transaction of $219,562.72. Following the transaction, the chief executive officer owned 56,152 shares in the company, valued at approximately $2,722,810.48. The trade was a 7.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 46,768 shares of company stock worth $2,560,222. Insiders own 50.13% of the company's stock.

About Phibro Animal Health

Phibro Animal Health Corporation NASDAQ: PAHC is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro's portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.